| CSK |
CSK: Tyrosine-protein kinase CSK |
IGHE |
IGHE: Ig epsilon chain C region |
4.685 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
DNM1 |
DNM1, DNM: Dynamin-1 |
4.685 |
Evidence |
|
| AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
4.685 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
IGHE |
IGHE: Ig epsilon chain C region |
4.685 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
GRB10 |
IPI00012752 |
4.685 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
4.685 |
Evidence |
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
ELTD1 |
ELTD1, RP11-143H12.1-002: EGF, latrophilin and seven transmembrane domain contai |
4.685 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
C6orf21 |
LY6G6F, C6orf21, G6F, LY6G6D, NG32: Lymphocyte antigen 6 complex locus protein G |
4.685 |
Evidence |
|
| VDAC1 |
VDAC1, VDAC: Voltage-dependent anion-selective channel protein 1 |
BMF |
BMF: Bcl-2-modifying factor |
4.685 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
4.685 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
4.685 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
GRB10 |
IPI00012752 |
4.685 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
PCGF6 |
PCGF6, MBLR, RNF134: Polycomb group RING finger protein 6 |
4.685 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
PCDH1 |
PCDH1: Protocadherin-1 precursor |
4.685 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
GRB10 |
IPI00012752 |
4.685 |
Evidence |
|
| SYN1 |
SYN1: Synapsin-1 |
CTTN |
CTTN, EMS1: Src substrate cortactin |
4.685 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
C9orf88 |
IPI00456750 |
4.685 |
Evidence |
|
| CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
4.685 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CRK |
CRK: Proto-oncogene C-crk |
4.685 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
4.685 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
4.685 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
4.685 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
GRB10 |
IPI00012752 |
4.685 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
4.685 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
GRB10 |
IPI00012752 |
4.685 |
Evidence |
|